Axsome Therapeutics Inc. (AXSM)
NASDAQ: AXSM
· Real-Time Price · USD
109.20
0.45 (0.41%)
At close: Aug 15, 2025, 3:59 PM
108.00
-1.10%
After-hours: Aug 15, 2025, 07:57 PM EDT
Axsome Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 150.04M | 121.46M | 118.77M | 104.76M | 87.17M | 75M | 71.53M | 57.79M | 46.7M | 94.58M | 24.37M | 16.85M | 8.82M | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 13.45M | 9.79M | 10.51M | 8.44M | 8.05M | 8.13M | 7.38M | 6.53M | 4.6M | 7.56M | 2.29M | 1.92M | 982.84K | 311.7K | 307.41K | 299.74K | 277.42K | 8.33K |
Gross Profit | 136.59M | 111.67M | 108.25M | 96.33M | 79.11M | 66.87M | 64.15M | 51.26M | 42.1M | 87.02M | 22.08M | 14.92M | 7.84M | -311.7K | -307.41K | -299.74K | -277.42K | -8.33K |
Operating Income | -36.71M | -56.98M | -72.62M | -62.62M | -78.05M | -68.69M | -98.11M | -62.12M | -65.06M | -6.54M | -55.72M | -42.45M | -40.04M | -38.29M | -32.61M | -33.41M | -30.85M | -27.84M |
Interest Income | n/a | n/a | 4.74M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -48.93M | -59.41M | -74.83M | -64.6M | -79.34M | -68.36M | -98.98M | -62.88M | -67.79M | -8.64M | -61.24M | -44.82M | -41.44M | -39.63M | -33.98M | -34.88M | -32.28M | -29.26M |
Net Income | -47.97M | -59.41M | -74.91M | -64.6M | -79.34M | -68.36M | -98.65M | -62.2M | -67.17M | -11.22M | -66.76M | -47.23M | -42.84M | -40.98M | -33.98M | -34.88M | -32.28M | -29.26M |
Selling & General & Admin | 130.28M | 120.79M | 113.27M | 95.56M | 103.55M | 98.97M | 86.81M | 83.19M | 78.94M | 74.19M | 61.5M | 40.89M | 31.16M | 25.7M | 18.83M | 20.23M | 16.34M | 11.25M |
Research & Development | 49.54M | 44.78M | 55.25M | 45.39M | 49.85M | 36.59M | 30.8M | 28.77M | 20.58M | 17.79M | 14.69M | 14.88M | 15.79M | 12.59M | 13.78M | 13.18M | 14.5M | 16.6M |
Other Expenses | n/a | 3.08M | 12.59M | 18M | 3.75M | 177K | 50.7M | 1.43M | 7.64M | 1.57M | 1.61M | 1.61M | 925.65K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 179.82M | 168.66M | 181.29M | 158.95M | 157.16M | 135.56M | 168.32M | 113.38M | 101.11M | 93.56M | 77.8M | 57.38M | 47.88M | 38.29M | 32.61M | 33.41M | 30.85M | 27.84M |
Interest Expense | -1.83M | -2.43M | 6.95M | 1.98M | 1.3M | 1.08M | 702K | 757K | 2.73M | 2.26M | 1.32M | 2.41M | 2.26M | 1.34M | 1.37M | 1.48M | 1.44M | 1.42M |
Selling & Marketing Expenses | n/a | n/a | -54.3M | n/a | 30.3M | 24M | 24.1M | 28.1M | 26.7M | 21.4M | -36.26M | -443 | -140 | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 193.27M | 178.44M | 189.97M | 167.39M | 165.21M | 143.69M | 175.69M | 119.91M | 105.7M | 101.11M | 80.09M | 59.3M | 48.86M | 38.29M | 32.61M | 33.41M | 30.85M | 27.84M |
Income Tax Expense | -960K | n/a | 85K | n/a | n/a | n/a | -3.6M | 678K | -617K | 2.58M | 5.52M | 2.41M | 1.4M | 1.34M | n/a | n/a | n/a | 262.76K |
Shares Outstanding (Basic) | 49.44M | 48.87M | 48.54M | 48.14M | 47.57M | 47.39M | 47.33M | 47.12M | 43.67M | 43.52M | 43.45M | 41.7M | 39.08M | 38.32M | 37.76M | 37.68M | 37.6M | 37.43M |
Shares Outstanding (Diluted) | 49.44M | 48.87M | 48.54M | 48.14M | 47.57M | 47.39M | 47.33M | 47.12M | 43.67M | 43.52M | 43.45M | 41.7M | 39.08M | 38.32M | 37.76M | 37.68M | 37.6M | 37.43M |
EPS (Basic) | -0.97 | -1.22 | -1.54 | -1.34 | -1.67 | -1.44 | -2.08 | -1.32 | -1.54 | -0.26 | -1.54 | -1.13 | -1.1 | -1.07 | -0.9 | -0.93 | -0.86 | -0.78 |
EPS (Diluted) | -0.97 | -1.22 | -1.54 | -1.34 | -1.67 | -1.44 | -2.08 | -1.32 | -1.54 | -0.26 | -1.54 | -1.13 | -1.1 | -1.07 | -0.9 | -0.93 | -0.86 | -0.78 |
EBITDA | -36.71M | -56.98M | -70.54M | -60.56M | -78.05M | -65.44M | -96.53M | -60.38M | -62.91M | -4.71M | -57.9M | -40.45M | -37.91M | -37.98M | -32.3M | -33.11M | -30.57M | -27.84M |
EBIT | -47.1M | -61.84M | -72.62M | -62.62M | -78.05M | -67.28M | -98.27M | -62.12M | -65.06M | -6.37M | -59.92M | -42.41M | -39.18M | -38.29M | -32.61M | -33.41M | -30.85M | -27.84M |
Depreciation & Amortization | n/a | 4.86M | 2.07M | 2.06M | 1.99M | 1.83M | 1.74M | 2.09M | 2.15M | 1.98M | 2.02M | 1.96M | 1.27M | 311.7K | 307.41K | 299.74K | 277.42K | 8.33K |